Home

About Us

• Company Overview
• Background & History
• Mission Statement
• Our Founder
• Locations

Products

• Synera^®
• Adasuve^®

Therapy Areas

• Local Dermal Analgesia

Business Development

• Business Development
• International Partnerships
• Partner of Choice

Careers

• Contact Us
• News

• Galen US Inc. Acquires First Inhaled Therapy Approved to Treat Agitation Associated with Schizophrenia and Bipolar I Disorder, Announces Revised La

• Less Pain for Patients Suffering from Needle Stick Discomfort
  

• Galen expands into US with cancer therapy drug

• Galen Signs Exclusive Deal in Europe
  

• Events
• Site map
• Privacy Policy
• Terms & conditions